Seggern Christopher Von - Net Worth and Insider Trading
Seggern Christopher Von Net Worth
The estimated net worth of Seggern Christopher Von is at least $150,720 dollars as of 2024-06-08. Seggern Christopher Von is the Chief Commercial Officer of Xenon Pharmaceuticals Inc and owns about 4,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $150,720. Details can be seen in Seggern Christopher Von's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Seggern Christopher Von has not made any transactions after 2021-12-06 and currently still holds the listed stock(s).
Transaction Summary of Seggern Christopher Von
Seggern Christopher Von Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seggern Christopher Von owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Seggern Christopher Von’s form 4 insider trades.
Insider Ownership Summary of Seggern Christopher Von
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2021-12-06 | Chief Commercial Officer |
Seggern Christopher Von Latest Holdings Summary
Seggern Christopher Von currently owns a total of 1 stock. Seggern Christopher Von owns 4,000 shares of Xenon Pharmaceuticals Inc (XENE) as of December 6, 2021, with a value of $150,720.
Latest Holdings of Seggern Christopher Von
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2021-12-06 | 4,000 | 37.68 | 150,720 |
Holding Weightings of Seggern Christopher Von
Seggern Christopher Von Form 4 Trading Tracker
According to the SEC Form 4 filings, Seggern Christopher Von has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the acquisition of 4,000 shares on December 6, 2021, which cost Seggern Christopher Von around $97,600.
Insider Trading History of Seggern Christopher Von
- 1
Seggern Christopher Von Trading Performance
GuruFocus tracks the stock performance after each of Seggern Christopher Von's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seggern Christopher Von is 22.24%. GuruFocus also compares Seggern Christopher Von's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seggern Christopher Von within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seggern Christopher Von's insider trading performs compared to the benchmark.
Performance of Seggern Christopher Von
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.56 | | | | | |
| Relative Return to S&P 500(%) | 23.29 | | | | | |
Seggern Christopher Von Ownership Network
Seggern Christopher Von Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Seggern Christopher Von is the Chief Commercial Officer of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Seggern Christopher Von made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 150,477 shares made by Simon N. Pimstone , a net sale of 26,576 shares made by Gary Patou , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 256,637 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 256,637 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Seggern Christopher Von Mailing Address
Above is the net worth, insider trading, and ownership report for Seggern Christopher Von. You might contact Seggern Christopher Von via mailing address: 200 - 3650 Gilmore Way, Burnaby A1 V5g 48w.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
